Samantha B. Shapiro, from the Jewish General Hospital in Montreal, and colleagues conducted an active comparator, new user cohort study to examine whether use of GLP-1 receptor agonists is associated ...

Independent. In print. In your mailbox. Inexpensive, too! Subscribe today and get a full year of Mother Jones for just $19.95.